Management of hidradenitis suppurativa in pregnancy

Powell Perng, John G. Zampella, Ginette A. Okoye

Research output: Contribution to journalArticlepeer-review

18 Scopus citations


Hidradenitis suppurativa is a debilitating inflammatory skin disease with a chronic course and often disappointing response to treatment. Though a minority of persons (20%) reports symptom remission during pregnancy, the vast majority experiences no relief (72%), and few experience clinical deterioration (8%). Disease flares are also observed post-partum. The pathophysiological basis for pregnancy-associated fluctuations in clinical status is currently unknown. Because most women with HS require ongoing management throughout pregnancy, it is important to evaluate the suitability and safety of current treatment options for pregnant women. The following review will outline current management strategies for HS and their compatibility with pregnancy and lactation.

Original languageEnglish (US)
JournalJournal of the American Academy of Dermatology
StateAccepted/In press - 2016


  • Hidradenitis suppurativa
  • Inflammation
  • Inflammatory skin disease
  • Lactation
  • Post-partum
  • Pregnancy

ASJC Scopus subject areas

  • Dermatology


Dive into the research topics of 'Management of hidradenitis suppurativa in pregnancy'. Together they form a unique fingerprint.

Cite this